You have 9 free searches left this month | to do more

apixaban

Apixaban is a drug used to treat Atrial Fibrillation, Venous Thromboembolism, Pulmonary Embolism, and other conditions. Apixaban is being actively studied in 48 studies and prior, has been studied in 78.

Top SponsorsTop SitesTop Investigators
Bristol-Myers SquibbLocal InstitutionJeffrey Kline
PfizerDuke University Medical CenterJessica Franklin
BayerHenry Ford HospitalScott C. Woller, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Apixaban for Extended Anticoagulation (APIDULCIS)
Active, not recruiting
  • Venous Thromboembolism
  • Anticoagulants
  • Apixaban
  • Firenze, Italy
    Daniela Poli
2022-03-10
Mar 10, 2022
A
Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension
Recruiting
  • Intrahepatic Non Cirrhotic Portal Hypertension
  • Apixaban
  • Placebo
  • Clichy, France
    Beaujon hospital
2022-03-21
Mar 21, 2022
S
Apixaban in Patients With Left Ventricular Thrombus - 2021
Completed
  • Left Ventricular Thrombus
  • Dammam, Saudi Arabia
    Saud AlBabtain Cardiac Center
2022-01-12
Jan 12, 2022
B
Expanded Access for Apixaban
Available
    • Apixaban
    • Philadelphia, Pennsylvania
      Childrens Hospital Of Philadelphia
    2022-03-07
    Mar 7, 2022
    N
    Bariatric Surgery and Pharmacokinetics of Apixaban
    Recruiting
    • Obesity, Morbid
    • Apixaban
    • Trondheim, Norway
      St. Olavs University Hospital
    2022-03-14
    Mar 14, 2022
    T
    Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy - 2021
    Completed
    • Pancreas Cancer
    • +2 more
    • Apixaban
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Clinical Research Unit
    2021-12-06
    Dec 6, 2021
    P
    Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices
    Recruiting
    • Heart Failure
    • Apixaban
    • +2 more
    • Falls Church, Virginia
      Inova Fairfax Medical Campus
    2022-02-21
    Feb 21, 2022
    S
    Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care
    Not yet recruiting
    • COVID-19
    • Rawalpindi, Punjab, Pakistan
      Rawalpindi Medical University
    2022-02-22
    Feb 22, 2022
    U
    A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma - 2019
    Terminated
    Has Results
    • Anti-Xa Activity
    • apixaban
    • Vancouver, British Columbia, Canada
      Vancouver General Hospital
    2021-07-28
    Jul 28, 2021
    O
    COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
    Recruiting
    • Atrial Fibrillation
    • Ottawa, Ontario, Canada
      The Ottawa Hospital - General Campus
    2022-03-14
    Mar 14, 2022
    O
    Comparison of Bleeding Risk Between Rivaroxaban and Apixaban - 2018
    Completed
    • Venous Thromboembolism
    • Edmonton, Alberta, Canada
    • +3 more
    2022-03-21
    Mar 21, 2022
    I
    Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
    Suspended
    • Deep Venous Thrombosis
    • +4 more
    • apixaban
    • Murray, Utah
      Intermountain Medical Center
    2021-08-24
    Aug 24, 2021
    A
    A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
    Recruiting
    • Venous Thromboembolism
    • +2 more
    • Abelacimab
    • Apixaban
    • Detroit, Michigan
    • +1 more
    2022-03-16
    Mar 16, 2022
    U
    Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation - 2019
    Completed
    Has Results
    • Transient Ischemic Attack
    • +2 more
    • Torrance, California
    • +4 more
    2021-11-03
    Nov 3, 2021
    U
    Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients - 2020
    Completed
    • Pharmacokinetics
    • +2 more
    • Apixaban
    • Saskatoon, Saskatchewan, Canada
      Saskatchewan Health Authority
    2021-04-28
    Apr 28, 2021
    J
    Apixaban Pharmacokinetics in Bariatric Patients (APB) - 2020
    Completed
    Has Results
    • Bariatric Surgery
    • Obesity
    • Apixaban
    • Baltimore, Maryland
      The Johns Hopkins Center for Bariatric Surgery
    2020-12-01
    Dec 1, 2020
    A
    Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
    Recruiting
    • Atrial Fibrillation
    • End-stage Kidney Disease
    • Münster, Germany
      Universitätsklinikum Münster
    2021-04-26
    Apr 26, 2021
    S
    Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
    Active, not recruiting
    • Antiphospholipid Syndrome
    • Thrombosis
    • Columbus, Ohio
    • +1 more
    2021-08-24
    Aug 24, 2021
    M
    Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation - 2020
    Terminated
    Has Results
    • Atrial Fibrillation
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    2021-02-23
    Feb 23, 2021
    M
    Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) - 2019
    Terminated
    Has Results
    • Heparin-induced Thrombocytopenia
    • Heparin-induced Thrombocytopenia and Thrombosis
    • Apixaban
    • Boston, Massachusetts
    • +2 more
    2020-11-29
    Nov 29, 2020
    U
    Apixaban for Treatment of Embolic Stroke of Undetermined Source - 2021
    Completed
    • Embolic Stroke of Undetermined Source
    • Berlin, Germany
    • +15 more
    2021-10-12
    Oct 12, 2021
    S
    Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation - 2019
    Completed
    Has Results
    • Coronary Artery Bypass Grafting
    • +4 more
    • Fargo, North Dakota
      Sanford Health
    2020-12-28
    Dec 28, 2020
    O
    Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
    Recruiting
    • Venous Thromboembolism
    • Calgary, Alberta, Canada
    • +16 more
    2022-03-14
    Mar 14, 2022
    I
    DOT HeartMate 3 Study
    Recruiting
    • LVAD (Left Ventricular Assist Device) Thrombosis
    • HeartMate 3
    • Apixaban
    • Prague, Czechia
      Institute for Clinical and Experimental Medicine
    2022-04-07
    Apr 7, 2022
    M
    Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
    Recruiting
    • Cancer Patients
    • +2 more
    • Apixaban
    • London, Ontario, Canada
    • +1 more
    2021-07-30
    Jul 30, 2021